STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] CeriBell, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Ceribell insider sale reported on Form 4. Senior Vice President, Finance and PAO David Foehr sold 866 shares of Ceribell, Inc. (ticker CBLL) on 08/27/2025 at a weighted average price of $11.71. After the sale he is shown as beneficially owning 20,250 shares reported as direct ownership. The filing was signed by an attorney-in-fact on 08/29/2025. The form discloses the sale price range was $11.71–$11.72 and notes the reporting person will provide per-transaction detail upon request.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine insider sale disclosed; transaction appears procedural and fully reported.

The filing documents a straightforward disposition of 866 common shares by a named officer on 08/27/2025 at a weighted average price of $11.71. The report states remaining direct beneficial ownership of 20,250 shares. From a market-impact perspective this is a small, clearly disclosed insider sale with full price-range footnote and an undertaking to provide granular details if requested. No derivative transactions or other compensatory grants are reported.

TL;DR: Disclosure meets Section 16 reporting requirements; signed by attorney-in-fact.

The Form 4 indicates compliance with Section 16 timing and disclosure norms. The signature block shows the filing was executed by an attorney-in-fact for the reporting person on 08/29/2025. The inclusion of a weighted-average price footnote and the offer to supply per-trade detail is consistent with good disclosure practice. No indications of rule 10b5-1 plan or amendments are present on the form.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Foehr David

(Last) (First) (Middle)
C/O CERIBELL, INC.
360 N. PASTORIA AVENUE

(Street)
SUNNYVALE CA 94085

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior VP, Finance and PAO
3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/27/2025 S 866 D $11.71(1) 20,250 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.71 to $11.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
/s/ Louisa Daniels, Attorney-in-Fact for David Foehr 08/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the Ceribell (CBLL) Form 4 report?

The Form 4 reports that Senior VP David Foehr sold 866 shares of Ceribell common stock on 08/27/2025.

At what price were the Ceribell shares sold on this Form 4?

The shares were sold at a weighted average price of $11.71, with individual trade prices ranging from $11.71 to $11.72.

How many Ceribell shares does the reporting person own after the transaction?

The Form 4 shows the reporting person beneficially owns 20,250 shares following the reported sale.

When was the Form 4 signed and who signed it?

The Form 4 was signed on 08/29/2025 by Louisa Daniels as Attorney-in-Fact for David Foehr.

Does the Form 4 indicate the sale was part of a 10b5-1 plan?

No. The form does not check or state that the transaction was made pursuant to a 10b5-1 trading plan.
CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

428.83M
28.79M
10.43%
84.44%
3.61%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE